These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25679028)

  • 1. Ironing out VPS34 inhibition.
    Marsh T; Debnath J
    Nat Cell Biol; 2015 Jan; 17(1):1-3. PubMed ID: 25679028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.
    Ronan B; Flamand O; Vescovi L; Dureuil C; Durand L; Fassy F; Bachelot MF; Lamberton A; Mathieu M; Bertrand T; Marquette JP; El-Ahmad Y; Filoche-Romme B; Schio L; Garcia-Echeverria C; Goulaouic H; Pasquier B
    Nat Chem Biol; 2014 Dec; 10(12):1013-9. PubMed ID: 25326666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinderella finds her shoe: the first Vps34 inhibitor uncovers a new PI3K-AGC protein kinase connection.
    Bilanges B; Vanhaesebroeck B
    Biochem J; 2014 Dec; 464(2):e7-10. PubMed ID: 25395352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells.
    Pasquier B
    Autophagy; 2015 Apr; 11(4):725-6. PubMed ID: 25905679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34.
    Robke L; Laraia L; Carnero Corrales MA; Konstantinidis G; Muroi M; Richters A; Winzker M; Engbring T; Tomassi S; Watanabe N; Osada H; Rauh D; Waldmann H; Wu YW; Engel J
    Angew Chem Int Ed Engl; 2017 Jul; 56(28):8153-8157. PubMed ID: 28544137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo.
    Dowdle WE; Nyfeler B; Nagel J; Elling RA; Liu S; Triantafellow E; Menon S; Wang Z; Honda A; Pardee G; Cantwell J; Luu C; Cornella-Taracido I; Harrington E; Fekkes P; Lei H; Fang Q; Digan ME; Burdick D; Powers AF; Helliwell SB; D'Aquin S; Bastien J; Wang H; Wiederschain D; Kuerth J; Bergman P; Schwalb D; Thomas J; Ugwonali S; Harbinski F; Tallarico J; Wilson CJ; Myer VE; Porter JA; Bussiere DE; Finan PM; Labow MA; Mao X; Hamann LG; Manning BD; Valdez RA; Nicholson T; Schirle M; Knapp MS; Keaney EP; Murphy LO
    Nat Cell Biol; 2014 Nov; 16(11):1069-79. PubMed ID: 25327288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors.
    Pasquier B; El-Ahmad Y; Filoche-Rommé B; Dureuil C; Fassy F; Abecassis PY; Mathieu M; Bertrand T; Benard T; Barrière C; El Batti S; Letallec JP; Sonnefraud V; Brollo M; Delbarre L; Loyau V; Pilorge F; Bertin L; Richepin P; Arigon J; Labrosse JR; Clément J; Durand F; Combet R; Perraut P; Leroy V; Gay F; Lefrançois D; Bretin F; Marquette JP; Michot N; Caron A; Castell C; Schio L; McCort G; Goulaouic H; Garcia-Echeverria C; Ronan B
    J Med Chem; 2015 Jan; 58(1):376-400. PubMed ID: 25402320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening.
    Kim TM; Baek JH; Kim JH; Oh MS; Kim J
    Anal Biochem; 2015 Jul; 480():21-7. PubMed ID: 25862085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Characterization of VPS34 Lipid Kinase Inhibition by Small Molecules.
    Fassy F; Dureuil C; Lamberton A; Mathieu M; Michot N; Ronan B; Pasquier B
    Methods Enzymol; 2017; 587():447-464. PubMed ID: 28253972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34.
    Miller S; Tavshanjian B; Oleksy A; Perisic O; Houseman BT; Shokat KM; Williams RL
    Science; 2010 Mar; 327(5973):1638-42. PubMed ID: 20339072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.
    Murali P; Verma K; Rungrotmongkol T; Thangavelu P; Karuppasamy R
    Protein J; 2021 Feb; 40(1):41-53. PubMed ID: 33400087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib.
    Dyczynski M; Yu Y; Otrocka M; Parpal S; Braga T; Henley AB; Zazzi H; Lerner M; Wennerberg K; Viklund J; Martinsson J; Grandér D; De Milito A; Pokrovskaja Tamm K
    Cancer Lett; 2018 Oct; 435():32-43. PubMed ID: 30055290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds.
    Liu Y; Yang Q; Chen S; Li Z; Fu L
    Eur J Med Chem; 2023 Aug; 256():115467. PubMed ID: 37178482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34.
    Backer JM
    Biochem J; 2016 Aug; 473(15):2251-71. PubMed ID: 27470591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors.
    Hu DX; Patel S; Chen H; Wang S; Staben ST; Dimitrova YN; Wallweber HA; Lee JY; Chan GKY; Sneeringer CJ; Prangley MS; Moffat JG; Wu KC; Schutt LK; Salphati L; Pang J; McNamara E; Huang H; Chen Y; Wang Y; Zhao W; Lim J; Murthy A; Siu M
    J Med Chem; 2022 Sep; 65(17):11500-11512. PubMed ID: 34779204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34.
    Bartolini E; Van Moer K; Janji B
    Oncoimmunology; 2024; 13(1):2364958. PubMed ID: 38872753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis.
    Veldhoen RA; Banman SL; Hemmerling DR; Odsen R; Simmen T; Simmonds AJ; Underhill DA; Goping IS
    Oncogene; 2013 Feb; 32(6):736-46. PubMed ID: 22430212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.
    Liu X; Wang A; Liang X; Liu J; Zou F; Chen C; Zhao Z; Deng Y; Wu H; Qi Z; Wang B; Wang L; Liu F; Xu Y; Wang W; Fernandes SM; Stone RM; Galinsky IA; Brown JR; Loh T; Griffin JD; Zhang S; Weisberg EL; Zhang X; Liu J; Liu Q
    Oncotarget; 2016 Aug; 7(33):53515-53525. PubMed ID: 27447747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VPS34 Acetylation Controls Its Lipid Kinase Activity and the Initiation of Canonical and Non-canonical Autophagy.
    Su H; Yang F; Wang Q; Shen Q; Huang J; Peng C; Zhang Y; Wan W; Wong CCL; Sun Q; Wang F; Zhou T; Liu W
    Mol Cell; 2017 Sep; 67(6):907-921.e7. PubMed ID: 28844862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase.
    Liu Y; Hu M; Luo D; Yue M; Wang S; Chen X; Zhou Y; Wang Y; Cai Y; Hu X; Ke Y; Yang Z; Hu H
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2075-2086. PubMed ID: 28882875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.